Read + Share
Di Giacomo AM, Schenker M, Medioni J, Mandziuk S, et al. A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in
patients with solid tumors (POD1UM-203). ESMO Open 2024;9:102387.
PMID: 38401247
|
 |
|
Di Giacomo AM, Schenker M, Medioni J, Mandziuk S, et al. A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in
patients with solid tumors (POD1UM-203). ESMO Open 2024;9:102387.
PMID: 38401247
|
|
|
|